Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 916 AL 930

The Shape of Mitochondrial Dysfunction in Down Syndrome

Zamponi E, Helguera PR.

Dev Neurobiol. 2019 Jul;79(7):613-621. doi: 10.1002/dneu.22673. Epub 2019 Mar 13.

Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis

Albrecht F, Bisenius S, Neumann J, Whitwell J, Schroeter ML.

Neuroimage Clin. 2019;22:101722. doi: 10.1016/j.nicl.2019.101722. Epub 2019 Feb 19.

Imaging executive functions in Parkinson's disease: An activation likelihood estimation meta-analysis

Giehl K, Tahmasian M, Eickhoff SB, van Eimeren T.

Parkinsonism Relat Disord. 2019 Jun;63:137-142. doi: 10.1016/j.parkreldis.2019.02.015. Epub 2019 Feb 20.

Nitric Oxide, Iron and Neurodegeneration

Liu C, Liang MC, Soong TW.

Front Neurosci. 2019 Feb 18;13:114. doi: 10.3389/fnins.2019.00114. eCollection 2019.

Improved language production with transcranial direct current stimulation in progressive supranuclear palsy

Madden DL, Sale MV, O'Sullivan J, Robinson GA.

Neuropsychologia. 2019 Apr;127:148-157. doi: 10.1016/j.neuropsychologia.2019.02.022. Epub 2019 Mar 2.

The influence of dopaminergic medication on balance automaticity in Parkinson's disease

Workman CD, Thrasher TA.

Gait Posture. 2019 May;70:98-103. doi: 10.1016/j.gaitpost.2019.02.015. Epub 2019 Feb 22.

Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist

Nasrallah HA, Fedora R, Morton R.

Schizophr Res. 2019 Jun;208:217-220. doi: 10.1016/j.schres.2019.02.018. Epub 2019 Mar 2.

LRRK2 links genetic and sporadic Parkinson's disease

Kluss JH, Mamais A, Cookson MR.

Biochem Soc Trans. 2019 Apr 30;47(2):651-661. doi: 10.1042/BST20180462. Epub 2019 Mar 5.

Caught in the act: LRRK2 in exosomes

Wang S, West AB.

Biochem Soc Trans. 2019 Apr 30;47(2):663-670. doi: 10.1042/BST20180467. Epub 2019 Mar 5.

Inflammation, Infectious Triggers, and Parkinson's Disease

Caggiu E, Arru G, Hosseini S, Niegowska M, Sechi G, Zarbo IR, Sechi LA.

Front Neurol. 2019 Feb 19;10:122. doi: 10.3389/fneur.2019.00122. eCollection 2019.

Mitoepigenetics and Neurodegenerative Diseases

Coppedè F, Stoccoro A.

Front Endocrinol (Lausanne). 2019 Feb 19;10:86. doi: 10.3389/fendo.2019.00086. eCollection 2019.

Resting-state Functional MRI in Parkinsonian Syndromes

Filippi M, Sarasso E, Agosta F.

Mov Disord Clin Pract. 2019 Feb 8;6(2):104-117. doi: 10.1002/mdc3.12730. eCollection 2019 Feb.

Levodopa-induced myocardial infarction in a patient with Parkinson's disease and severe coronary artery disease

Ng CF, Tiau PW, Tan HJ, Norlinah MI.

J R Coll Physicians Edinb. 2019 Mar;49(1):37-39. doi: 10.4997/JRCPE.2019.108.

Systematic Review of Yoga and Balance: Effect on Adults With Neuromuscular Impairment

Green E, Huynh A, Broussard L, Zunker B, Matthews J, Hilton CL, Aranha K.

Am J Occup Ther. 2019 Jan/Feb;73(1):7301205150p1-7301205150p11. doi: 10.5014/ajot.2019.028944.

Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease

Kang UJ, Boehme AK, Fairfoul G, Shahnawaz M, Ma TC, Hutten SJ, Green A, Soto C.

Mov Disord. 2019 Apr;34(4):536-544. doi: 10.1002/mds.27646. Epub 2019 Mar 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias